Topics
Glioblastoma | Treatment | Targeted therapy | Angiogenes isinhibitors | Preoperative
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Angiogenes isinhibitors > Preoperative
Tanaka T, Tamura R, Takei J, Morimoto Y, Teshigawara A, Yamamoto
Y, Imai R, Kuranari Y, Tohmoto K, Hasegawa Y, Akasaki Y, Murayama
Y, Miyake K, Sasaki H.
An exploratory
prospective phase II study of preoperative neoadjuvant bevacizumab
and temozolomide for newly diagnosed glioblastoma.
J
Neurooncol. 2024 Jan 31. doi:
10.1007/s11060-023-04544-8. PMID:
38291182. Interventional
study. ˍ
Tanaka T, Tamura R, Takei J, Yamamoto Y, Akasaki Y, Murayama Y,
Miyake K, Sasaki H.
AB052. A
multicenter prospective exploratory phase II study of neoadjuvant
bevacizumab for newly diagnosed malignant glioma.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB052. doi:
10.21037/cco-24-ab052. PMID:
39295370. Interventional study. ˍ